Skip to content

Author

B. Kang

We have 2 of 29 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Trastuzumab plus nivolumab with gemcitabine and cisplatin as first-line therapy for HER2-positive unresectable biliary tract cancer: a phase 1b/2 trial

Biliary tract cancers (BTCs) are associated with poor outcomes despite recent incorporation of immune checkpoint inhibitors into first-line chemotherapy. Human epidermal growth factor receptor 2 (HER2) overexpression or amplification defines a therapeutically targetable subset of BTC but its integration into first-line...

Choong-kun Lee, Taek Chung, I. Kim et al. · 0 citations
Open access Sep 2026

Large Language Models in Multidisciplinary Decision-Making for Hepatopancreatobiliary Oncology: Retrospective Comparative Feasibility Study

LLM-generated treatment recommendations demonstrated moderate alignment with MDT decisions in HPB oncology, indicating that concordance alone is insufficient for evaluating LLMs as clinical decision support tools.

Jun-Jo Sung, Eui Hyuk Chong, Incheon Kang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.